SUBSCRIBE
SUBSCRIBE

Brandon May

Business
Brooklyn ImmunoTherapeutics, Overland ADCT BioPharma Name New CEOs
The biopharmaceutical industry saw two CEO appointments made today, including Howard J. Federoff, M.D., Ph.D., to Brooklyn ImmunoTherapeutics and Eric Koo to Overland ADCT BioPharma.
April 6, 2021
 · 
3 min read
 · 
Brandon May
Deals
Biotechs Bolstering Bank Accounts by Selling Stock This Week
Several new initial public offering (IPO) announcements have been made by international and U.S.-based biopharmaceutical and biotechnology companies in the past couple of days.
March 25, 2021
 · 
2 min read
 · 
Brandon May
Sven Kili_Vaticanconference2016, Bruce Levine_Cann
Business
Lyell Completes Cutting-Edge $65 Million Cell Therapy Facility
Lyell Immunopharma announced this week that it has completed construction of a $65 million, 70,000-square-foot LyFE Manufacturing Center, which the company will use to support clinical trials and meet cell therapy manufacturing needs.
March 25, 2021
 · 
3 min read
 · 
Brandon May
Genetown
Partner Therapeutics’ Leukine Shows Promise for Alzheimer’s in New Study
Study findings published in Alzheimer’s & Dementia: Translational Research and Clinical Interventions suggest Leukine® leads to significant reversal of cognitive impairment and normalizes blood-based biomarkers of dementia in patients with mild-to-moderate Alzheimer’s disease.
March 24, 2021
 · 
3 min read
 · 
Brandon May
SKYRIZI is the new option for psoriatic arthritis.
Policy
AbbVie Legal Complaint Alleges Alvotech Misappropriated Humira Trade Secrets
AbbVie has filed a legal complaint against Icelandic pharmaceutical company Alvotech for the latter’s alleged misappropriation of trade secrets involving the development of a generic version of AbbVie’s rheumatoid arthritis drug Humira.
March 24, 2021
 · 
3 min read
 · 
Brandon May
Business
From Hong Kong to Boston, New Biopharma Launches with Immune-based Pipeline
Zenas BioPharma announced it has launched a cross-border biopharmaceutical company based in both China and the U.S.
March 23, 2021
 · 
3 min read
 · 
Brandon May
photobyphm/Shutterstock
Drug Development
Novartis’ Radioligand Therapy Lives Up to Hype in Phase III Prostate Cancer Trial
Targeted radioligand therapy 177Lu-PSMA-617 from Novartis significantly improved overall survival (OS) and radiographic progression-free survival (rPFS) in patients with PSMA-positive metastatic castration-resistant prostate cancer.
March 23, 2021
 · 
3 min read
 · 
Brandon May
Courtesy of JHVEPhoto/GettyImages
Drug Development
FDA Cites Safety Concerns Over Pfizer and Lilly’s Osteoarthritis Drug Tanezumab
A briefing document from the U.S. FDA cites critical safety concerns with Pfizer and Eli Lilly’s anti-NGF osteoarthritis drug tanezumab, despite the fact that clinical trials have demonstrated the agent can help patients with osteoarthritis.
March 22, 2021
 · 
2 min read
 · 
Brandon May
Business
Oramed Forms Joint Venture Company to Develop Oral COVID-19 Vaccines
Jerusalem’s clinical-stage pharmaceutical company Oramed Pharmaceuticals is forming a joint venture with Premas Biotech to develop novel oral COVID-19 vaccine candidates.
March 22, 2021
 · 
3 min read
 · 
Brandon May
Aleksander Kalka/NurPhoto via Getty Images
Business
Fujifilm Set to Build Massive $2 Billion CDMO in North Carolina
The investment made to build this end-to-end cell culture biopharmaceutical contract development and manufacturing organization facility clocked in at approximately $2 billion.
March 19, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Idera’s Melanoma Candidate Hits Snag in Phase III Trial
A Phase III trial from Idera Pharmaceuticals did not reach the primary endpoint of ORR in patients with anti-PD-1 refractory advanced melanoma treated with a combination regimen comprising ipilimumab and the company’s investigational agent tilsotolimod.
March 19, 2021
 · 
3 min read
 · 
Brandon May
Policy
Top Research Scientists Suggest Needle-Free COVID-19 Vaccines Are on the Way
According to an interview with Soumya Swaminathan, the WHO’s chief scientist, the new investigational COVID-19 vaccines rely on alternative technologies and systems of delivery. Some include oral and nasal administration, while others use skin patches.
March 18, 2021
 · 
3 min read
 · 
Brandon May
Drug Development
Translate Bio’s mRNA Candidate Fails to Show Benefit in Cystic Fibrosis Trial
Findings from a second interim analysis of a first-in-human Phase I/II clinical trial of Translate Bio’s CF mRNA candidate, MRT5005, show the drug did not significantly improve lung function in patients with CF.
March 18, 2021
 · 
3 min read
 · 
Brandon May
Business
Valence/Repare Collab Capitalizes on AI to Optimize Precision Oncology Candidates
In recent years, AI-fueled drug discovery programs have risen dramatically, particularly in regard to rare diseases.
March 17, 2021
 · 
3 min read
 · 
Brandon May
Business
Merck Enters Into New Collab to Advance Neurodegenerative Candidates With Amathus
Amathus Therapeutics, a biopharmaceutical company working on small molecule modulators across diverse genetically defined diseases, has entered into a strategic collaboration with Merck to develop novel small molecule treatment candidates for neurodegenerative diseases.
March 17, 2021
 · 
3 min read
 · 
Brandon May
Load More